COR vs DHR
COR: North America's largest pharmaceutical and healthcare product distributor, serving pharmacies, hospitals, and health systems with branded and generic drugs, medical supplies, and specialty healthcare services. DHR: A diversified conglomerate applying advanced technologies and quality manufacturing across life sciences, diagnostics, environmental & applied solutions, and industrial products.
Side-by-side fundamentals
| Metric | COR | DHR | Edge |
|---|---|---|---|
| Price as of 2026-07-09 close | $302.46 | $195.98 | |
| Market cap as of 2026-07-10 | $58.8B | $137.8B | |
| P/E as of 2026-07-10 | 23.09 | 37.35 | COR lower |
| PEG as of 2026-07-10 | 2.03 | 3.97 | COR lower |
| Net margin as of 2026-07-10 | +0.8% | +14.9% | DHR higher |
| Gross margin as of 2026-07-10 | +3.8% | +59.0% | DHR higher |
| Operating margin as of 2026-07-10 | +0.8% | +19.2% | DHR higher |
| ROE as of 2026-07-10 | +115.9% | +7.1% | COR higher |
| ROA as of 2026-07-10 | +3.3% | +4.5% | DHR higher |
| Debt / equity as of 2026-07-10 | 3.65 | 0.35 | DHR lower |
| Revenue growth (YoY) as of 2026-07-10 | +6.0% | +4.0% | COR higher |
| Revenue CAGR (3y) SEC XBRL | +10.4% | -2.7% | COR higher |
| Dividend yield as of 2026-07-10 | +0.8% | +0.8% | DHR higher |
| Dividend streak (yrs) SEC XBRL | 4 | n/a | |
| Beta as of 2026-07-10 | 0.58 | 0.78 | |
| 1-year return as of 2026-07-09 close | +0.8% | -4.9% | COR higher |
Fundamentals: Finnhub, as of 2026-07-10. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-09.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.